MIR31 is a microRNA implicated in various cellular processes, including tumorigenesis and immune response regulation. Studies have identified MIR31 as a tumor suppressor in HepG2 and primary hepatocarcinoma cells, where it is transferred by HLSC-EVs [PMC8107725]. However, MIR31 also has the potential to act as an oncomir by repressing tumor suppressor genes like LATS2 and may indirectly promote genes associated with the cell cycle and tumorigenesis [PMC4067122]. Research has explored modulating MIR31 using morpholino oligomers to investigate its role in a dystrophic context [PMC4972457]. Additionally, MIR31 has been shown to regulate the expression of E-selectins and ICAM-1, which reduces neutrophil adhesion and leukocyte infiltration after a stroke [PMC6732937]. The expression of MIR31 can be modulated by infections that sustain CIITA expression or through epigenetic downregulation that leads to NFκB activation [PMC9591123]. The complexity of the MIR31 locus is highlighted by its ability to produce both microRNA and a long non-coding RNA (lnc-MIR31) through mutually exclusive pathways [PMC4972457]. In colorectal cancer subtypes, MIR31 expression outliers are biologically most similar to CMS4-mesenchymal tumors [PMC6590447], suggesting its involvement in metastatic processes potentially through targeting genes like WAVE3 [PMC3428347].
A G C -U gaa ggagagg GGCAA AUG UGGCAUAGC guu c ||||||| ||||| ||| ||||||||| ||| ccuuucU CCGUU UAC ACCGUAUCG caa u A A A Uc ggg
Disease | Description | Category | PubMed ID |
---|
Accession | MIMAT0000089 |
Description | Homo sapiens hsa-miR-31-5p mature miRNA |
Sequence | 8 - AGGCAAGAUGCUGGCAUAGCU - 28 |
Evidence |
experimental
cloned [1-3], Northern [1] |
Database links |
![]() ![]() ![]() |
Predicted targets |
![]() ![]() ![]() |
Accession | MIMAT0004504 |
Description | Homo sapiens hsa-miR-31-3p mature miRNA |
Sequence | 44 - UGCUAUGCCAACAUAUUGCCAU - 65 |
Evidence |
experimental
cloned [2] |
Database links |
![]() ![]() ![]() |
Predicted targets |
![]() ![]() ![]() |
|